Arconic could have more than 40% upside.
Alibaba is still a great unknown.
Ecommerce success and pricing power mean Lululemon could sustain growth into next year.
Even the negative analysts see upside in Foot Locker from here.
Web traffic and brand share data suggest Adidas could outpace Nike.
The approaching debt-ceiling debate in Congress could send bank stocks diving, if recent history offers any lessons.
Three analysts raised their price target on AMAT stock, the lowest of which implies about 40% upside.
What's next for Valeant Pharmaceuticals shares?
Bad news overshadowed an earnings beat for L Brands.
Walmart brought in $1.08 billion in the recent quarter versus $1.07 billion expected.
Citigroup cut its rating for the struggling generic drug maker to 'neutral'.
Strong demand for the Model 3 is about to drive up Tesla's stock price, Baird says.
The retailer announced weaker-than-expected second quarter results on Tuesday.
Alibaba to $175? SunTrust thinks so.
Target beat earnings, revenue and same-store sales expectations.